IBDEI0FO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7547,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,7547,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,7547,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,7548,0)
 ;;=710.9^^49^558^10
 ;;^UTILITY(U,$J,358.3,7548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7548,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,7548,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,7548,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,7549,0)
 ;;=714.0^^49^558^98
 ;;^UTILITY(U,$J,358.3,7549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7549,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,7549,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,7549,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,7550,0)
 ;;=714.30^^49^558^99
 ;;^UTILITY(U,$J,358.3,7550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7550,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,7550,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,7550,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,7551,0)
 ;;=744.89^^49^558^38
 ;;^UTILITY(U,$J,358.3,7551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7551,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,7551,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,7551,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,7552,0)
 ;;=759.6^^49^558^116
 ;;^UTILITY(U,$J,358.3,7552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7552,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,7552,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,7552,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,7553,0)
 ;;=759.82^^49^558^62
 ;;^UTILITY(U,$J,358.3,7553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7553,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,7553,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,7553,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,7554,0)
 ;;=802.4^^49^558^36
 ;;^UTILITY(U,$J,358.3,7554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7554,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,7554,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,7554,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,7555,0)
 ;;=870.1^^49^558^53
 ;;^UTILITY(U,$J,358.3,7555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7555,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,7555,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,7555,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,7556,0)
 ;;=870.2^^49^558^34
 ;;^UTILITY(U,$J,358.3,7556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7556,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,7556,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,7556,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,7557,0)
 ;;=870.3^^49^558^84
 ;;^UTILITY(U,$J,358.3,7557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7557,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,7557,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,7557,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,7558,0)
 ;;=870.9^^49^558^69
 ;;^UTILITY(U,$J,358.3,7558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7558,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,7558,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,7558,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,7559,0)
 ;;=871.0^^49^558^70
 ;;^UTILITY(U,$J,358.3,7559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7559,1,3,0)
 ;;=3^Ocular Laceration
 ;;^UTILITY(U,$J,358.3,7559,1,4,0)
 ;;=4^871.0
 ;;^UTILITY(U,$J,358.3,7559,2)
 ;;=^274886
 ;;^UTILITY(U,$J,358.3,7560,0)
 ;;=871.1^^49^558^71
 ;;^UTILITY(U,$J,358.3,7560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7560,1,3,0)
 ;;=3^Ocular Laceration w/ Prolapse
 ;;^UTILITY(U,$J,358.3,7560,1,4,0)
 ;;=4^871.1
 ;;^UTILITY(U,$J,358.3,7560,2)
 ;;=^274887
